Brainsway Ltd (BWAY)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $377.98M
Last updated: Nov 17, 2026 at 4:15 PM ET
Brainsway Ltd (BWAY) Statistics
Brainsway (BWAY) has a market cap of $377.98M. Its share count is down 41.54% from a year earlier. Revenue grew 33.36% over the last 12 months from the 12 months before.
Total Valuation
| Market Cap | $377.98M |
|---|---|
| Latest price (Nov 17, 2026) | $9.11 |
Key Dates
| Last Earnings Date | Nov 10, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.1x and 2.5x.
| P/E Ratio | 25.0x |
|---|---|
| Forward P/E | 11.1x |
| P/S Ratio | 3.1x |
| Forward P/S | 5.4x |
| P/B Ratio | 2.5x |
| P/FCF Ratio | 21.1x |
| P/OCF Ratio | 29.2x |
| PEG Ratio | 0.5 |
Price Statistics
The stock is up 15.61% over 52 weeks and trades 24.46% below its 50-day average.
| Beta (1Y) | 2.09 |
|---|---|
| 52-Week Change | +15.61% |
| 1-Month Change | -24.02% |
| 3-Month Change | -39.95% |
| 6-Month Change | -38.82% |
| 5-Year Change | +177.75% |
| Total Return (1Y) | +15.61% |
| Total Return (3Y CAGR) | +56.41% |
| Total Return (5Y CAGR) | +17.94% |
| Return vs SPY (1Y) | +11.72% |
| Max Drawdown (1Y) | -46.94% |
| Max Drawdown (3Y) | -46.94% |
| Sharpe Ratio (1Y) | 0.38 |
| Correlation with SPY (1Y) | 0.52 |
| 50-Day Average | $12.06 |
| 200-Day Average | $13.85 |
| 52-Week Range | $7.13 to $17.40 |
| RSI (14 Days) | 31.4 |
| Average Volume (20 Days) | 131.03K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.89x current liabilities.
| Current Ratio | 2.89x |
|---|---|
| Quick Ratio | 2.62x |
| Interest Coverage | 4.49x |
Returns and Efficiency
Return on equity is 12.38% over the last 12 months, against a 5-year average of -7.13%.
| Return on Equity (ROE) | 12.38% |
|---|---|
| Return on Assets (ROA) | 8.09% |
| Return on Capital Employed (ROCE) | 10.95% |
| ROE (5Y Average) | -7.13% |
| ROA (5Y Average) | -5.21% |
| ROIC (5Y Average) | -6.15% |
| Asset Turnover | 0.55x |
| Inventory Turnover | 2.09x |
| Receivables Turnover | 9.59x |
| Cash Conversion Cycle | 158 days |
Scores
BWAY has an Altman Z-Score of 3.16, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.16 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $65.47M over the last 12 months.
| Revenue | $65.47M |
|---|---|
| Revenue Growth (YoY) | +33.36% |
| Gross Profit | $49.80M |
| Operating Income | $8.92M |
| Pretax Income | $10.06M |
| Net Income | $10.18M |
| EBITDA | $12.44M |
| EBIT | $10.70M |
| Reported EPS (TTM) | $0.36 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 65.33% of the $125.89M in total assets.
| Cash and Equivalents | $30.05M |
|---|---|
| Working Capital | $53.32M |
| Shareholder Equity | $82.24M |
| Total Assets | $125.89M |
| Total Liabilities | $43.66M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $3.33M of capital spending, operating cash flow left $9.60M of free cash flow.
| Operating Cash Flow | $12.93M |
|---|---|
| Capital Expenditures | $3.33M |
| Free Cash Flow | $9.60M |
| FCF Per Share | $0.24 |
| Depreciation and Amortization | $1.74M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 13.63%, against a 5-year average of -13.49%.
| Gross Margin | 76.06% |
|---|---|
| Operating Margin | 13.63% |
| Pretax Margin | 15.36% |
| Net Margin | 15.55% |
| EBITDA Margin | 19.00% |
| EBIT Margin | 16.35% |
| FCF Margin | 14.67% |
| Gross Margin (5Y Average) | 75.07% |
| Operating Margin (5Y Average) | -13.49% |
| Net Margin (5Y Average) | -12.47% |
Growth
Revenue grew 24.33% a year over 3 years.
| Revenue Growth (3Y CAGR) | +24.33% |
|---|---|
| Revenue Growth (5Y CAGR) | +18.81% |
Dividends and Yields
BWAY does not pay a dividend. Its free cash flow yield is 4.74%.
| Earnings Yield | 4.00% |
|---|---|
| FCF Yield | 4.74% |
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 2-for-1 forward split on Mar 4, 2026.
| Last Split Date | Mar 4, 2026 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 12 similar companies, BWAY has the 7th highest P/S.
P/S RatioPeer median 3.2x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.88%
| P/S Ratio | 3.1x vs 3.2x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +33.36% vs +13.88% median |
Analyst Forecast
Consensus estimates put revenue growth at 27.68% and EPS growth at 66.36% a year over the next 3 fiscal years.
| Revenue Growth Forecast (3Y CAGR) | +27.68% |
|---|---|
| EPS Growth Forecast (3Y CAGR) | +66.36% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BWAY
What is BWAY's market cap?
Brainsway has a market cap of $377.98M.
What is BWAY's P/E ratio?
Brainsway has a trailing P/E ratio of 25.0x and a forward P/E of 11.1x.
How many shares of BWAY are outstanding?
Brainsway has 22.22M shares outstanding. The count is down 41.54% from a year earlier.
Does BWAY pay a dividend?
No. Brainsway does not pay a dividend.
BWAY pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors